GlassScriptPhysician profile
Michael William Kipp
NPI 1841544764
$2,162.93
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $1,097 · 2023: $567 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,603.60 | 2021-2023 | Proclaim, Octrode |
| Nevro Corp. | $172.53 | 2022-2023 | Senza |
| Vertos Medical, INC. | $138.98 | 2024 | Mild Device Kit |
| Almatica Pharma LLC | $68.52 | 2021-2023 | Gralise |
| Electronic Waveform Lab, INC. | $52.63 | 2021-2024 | |
| Biodelivery Sciences International, INC. | $27.70 | 2021 | |
| Grt US Holding, INC. | $26.15 | 2022 | |
| Virtus Pharmaceuticals LLC | $20.19 | 2021 | |
| Nalu Medical, INC. | $15.00 | 2023 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.00 | 2023 | Relistor |
| Arbor Pharmaceuticals, INC. | $12.52 | 2021 | |
| Collegium Pharmaceutical, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.